Read More Pharma Industry News Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419 Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer… bypharmanewsdailyJuly 14, 2020